Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The purpose of this study is to investigate CYP2C9 inhibition by BIA 9-1067 through the assessment of its effect on the pharmacokinetics of S-warfarin, a substrate of CYP2C9.
Epistemonikos ID: 2cbaf04425a3994c533ff8327815a84fecb3937c
First added on: May 11, 2024